Pharmacokinetic and pharmacodynamic analysis of circulating biomarkers of anti-NRP1, a novel antiangiogenesis agent, in two phase I trials in patients with advanced solid tumors. [electronic resource]
Producer: 20130611Description: 6040-8 p. digitalISSN:- 1557-3265
- Angiogenesis Inhibitors -- pharmacokinetics
- Animals
- Antibodies, Monoclonal -- pharmacokinetics
- Antineoplastic Agents -- pharmacokinetics
- Biomarkers -- blood
- Glycosylphosphatidylinositols -- blood
- Humans
- Macaca fascicularis
- Neoplasm Staging
- Neoplasms -- drug therapy
- Neuropilin-1 -- blood
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.